These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 21984611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FGF23 and primary hyperparathyroidism: is there a link?
    Bilha SC, Gatu AA, Velicescu C, Bilha A, Florescu A, Branisteanu D.
    Endokrynol Pol; 2020; 71(4):306-312. PubMed ID: 32598019
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism.
    Kobayashi K, Imanishi Y, Miyauchi A, Onoda N, Kawata T, Tahara H, Goto H, Miki T, Ishimura E, Sugimoto T, Ishikawa T, Inaba M, Nishizawa Y.
    Eur J Endocrinol; 2006 Jan; 154(1):93-9. PubMed ID: 16381997
    [Abstract] [Full Text] [Related]

  • 6. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter?
    Carsello CB, Yen TW, Wang TS.
    Surgery; 2012 Oct; 152(4):575-81; discussion 581-3. PubMed ID: 23021134
    [Abstract] [Full Text] [Related]

  • 7. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
    Farahnak P, Lärfars G, Sten-Linder M, Nilsson IL.
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
    [Abstract] [Full Text] [Related]

  • 8. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
    Taal MW, Thurston V, McIntyre NJ, Fluck RJ, McIntyre CW.
    Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study.
    Ardawi MS, Al-Sibiany AM, Bakhsh TM, Rouzi AA, Qari MH.
    Osteoporos Int; 2012 Jun; 23(6):1789-97. PubMed ID: 22041864
    [Abstract] [Full Text] [Related]

  • 11. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.
    Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F, Borretta G.
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):321-8. PubMed ID: 10435057
    [Abstract] [Full Text] [Related]

  • 12. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
    Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellström D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE.
    Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
    [Abstract] [Full Text] [Related]

  • 13. Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism.
    Tebben PJ, Singh RJ, Clarke BL, Kumar R.
    Mayo Clin Proc; 2004 Dec; 79(12):1508-13. PubMed ID: 15595334
    [Abstract] [Full Text] [Related]

  • 14. Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism.
    Meyer SK, Zorn M, Frank-Raue K, Büchler MW, Nawroth P, Weber T.
    Eur J Endocrinol; 2009 Feb; 160(2):275-81. PubMed ID: 19004983
    [Abstract] [Full Text] [Related]

  • 15. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
    Beyer TD, Solorzano CC, Prinz RA, Babu A, Nilubol N, Patel S.
    Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
    [Abstract] [Full Text] [Related]

  • 16. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI, Maestro ML, Calvo N, De La Orden V, Pérez Flores I, Vidaurreta M, Valero R, Fernández-Pérez C, Barrientos A.
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [Abstract] [Full Text] [Related]

  • 17. Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
    Iguchi A, Kazama JJ, Yamamoto S, Yoshita K, Watanabe Y, Iino N, Narita I.
    Nephron; 2015 Nov; 131(3):161-6. PubMed ID: 26551233
    [Abstract] [Full Text] [Related]

  • 18. Regulation of fibroblast growth factor 23 production in bone in uremic rats.
    Saji F, Shiizaki K, Shimada S, Okada T, Kunimoto K, Sakaguchi T, Hatamura I, Shigematsu T.
    Nephron Physiol; 2009 Nov; 111(4):p59-66. PubMed ID: 19339809
    [Abstract] [Full Text] [Related]

  • 19. Attenuated Dentin Matrix Protein 1 Enhances Fibroblast Growth Factor 23 in Calvaria in a Primary Hyperparathyroidism Model.
    Nagata Y, Imanishi Y, Ohara M, Maeda-Tateishi T, Miyaoka D, Hayashi N, Kurajoh M, Emoto M, Inaba M.
    Endocrinology; 2019 May 01; 160(5):1348-1358. PubMed ID: 30916761
    [Abstract] [Full Text] [Related]

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.